Craig Strasnick received his bachelor of science in business administration from Northeastern University in Boston, Massachusetts, and has facilitated the development of numerous medical testing products offered on international and domestic markets. As the president and CEO of Salem, Massachusetts based Commonwealth Diagnostics International, Craig Strasnick guides the organization in its diverse operations, one of which is supporting clinical research.
Commonwealth Diagnostics International participates in diverse research and development initiatives associated with the prevention, diagnosis, and treatment of a wide range of functional gastrointestinal disorders. With a sophisticated laboratory in Salem, Massachusetts, and experience in managing diagnostic methods and clinical trials, the company has partnered with various sponsors and taken part in numerous research studies.
The lab management team at Commonwealth Diagnostics International provides expertise in formulating analytical protocols and methods uniquely designed for clinical trials and can meet regulatory requirements while accommodating studies ranging from small to large-scale. The laboratory staff at Commonwealth Diagnostics International have successfully worked with pharmaceutical sponsors, principal investigators, and contract research organizations, and have also facilitated Phase II and III clinical trials.
